{"id":"NCT04214639","sponsor":"Bausch Health Americas, Inc.","briefTitle":"Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris","officialTitle":"A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-01-17","primaryCompletion":"2021-01-18","completion":"2021-01-18","firstPosted":"2020-01-02","resultsPosted":"2024-02-01","lastUpdate":"2024-02-01"},"enrollment":183,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Acne Vulgaris"],"interventions":[{"type":"DRUG","name":"IDP-126 Gel","otherNames":[]},{"type":"DRUG","name":"IDP-126 Vehicle Gel","otherNames":[]}],"arms":[{"label":"IDP-126 Gel","type":"EXPERIMENTAL"},{"label":"IDP-126 Vehicle Gel","type":"PLACEBO_COMPARATOR"}],"summary":"This is a multicenter, randomized, double-blind, vehicle-controlled, 12-week study designed to assess the safety, tolerability, and efficacy of IDP-126 Gel in comparison IDP-126 Vehicle Gel at Weeks 2, 4, 8, and 12.","primaryOutcome":{"measure":"Absolute Change From Baseline to Week 12 in Inflammatory Lesion Counts","timeFrame":"12 weeks","effectByArm":[{"arm":"IDP-126 Gel","deltaMin":-27.7,"sd":9.55},{"arm":"IDP-126 Vehicle Gel","deltaMin":-21.7,"sd":8.79}],"pValues":[]},"eligibility":{"minAge":"9 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":9},"locations":{"siteCount":13,"countries":["United States","Canada"]},"refs":{"pmids":["40377868","38724841"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":122},"commonTop":["Application site pain","Erythema"]}}